Application and methodology of in vivo K x‐ray fluorescence of Pb in bone (impact of KXRF data in the epidemiology of lead toxicity, and consistency of the data generated by updated systems)

K x-ray fluorescence (KXRF) technology has been used to make in vivo measurements of lead in bone for more than three decades. The data obtained are beneficial to research on lead toxicity as well as, in certain circumstances, the practice of occupational and environmental medicine. This paper reviews the impact of KXRF data on epidemiologic research involving lead toxicity and demonstrates that bone lead is and will continue to be a valuable biomarker in addressing long-term health effects related to cumulative exposure. The KXRF system has been improved and upgraded several times ever since it was first used. The consistency of the data obtained from these KXRF systems has been investigated in many studies. This paper provides an overview of the factors that will affect the data generated by the KXRF systems. A calibration problem encountered in one of the major KXRF laboratories is described, and the approach taken to solve the problem is discussed. Despite all the theoretical considerations, there are still some important practical challenges to the intercalibration of KXRF instruments both within the laboratory, and between laboratories. Copyright © 2007 John Wiley & Sons, Ltd.

[1]  M. Scott,et al.  Bone lead concentrations assessed by in vivo X-ray fluorescence. , 2000, Clinical chemistry.

[2]  Joel Schwartz,et al.  Lead, Diabetes, Hypertension, and Renal Function: The Normative Aging Study , 2004, Environmental health perspectives.

[3]  E. Guallar,et al.  Lead Exposure and Cardiovascular Disease—A Systematic Review , 2006, Environmental health perspectives.

[4]  B. Schwartz,et al.  Cumulative Lead Dose and Cognitive Function in Adults: A Review of Studies That Measured Both Blood Lead and Bone Lead , 2006, Environmental health perspectives.

[5]  A. Todd.  Coherent scattering and matrix correction in bone-lead measurements. , 2000, Physics in medicine and biology.

[6]  Howard Hu,et al.  Fetal Lead Exposure at Each Stage of Pregnancy as a Predictor of Infant Mental Development , 2004, Environmental health perspectives.

[7]  S. Fienberg,et al.  Bone lead levels in adjudicated delinquents. A case control study. , 2002, Neurotoxicology and teratology.

[8]  Brian S. Schwartz,et al.  The Epidemiology of Lead Toxicity in Adults: Measuring Dose and Consideration of Other Methodologic Issues , 2006, Environmental health perspectives.

[9]  J O Christoffersson,et al.  Kinetics of lead in bone and blood after end of occupational exposure. , 1991, Pharmacology & toxicology.

[10]  S. J. Rothenberg,et al.  An agreed statement on calculating lead concentration and uncertainty in XRF in vivo bone lead analysis. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[11]  L J Somervaille,et al.  In vivo measurement of lead in bone using x-ray fluorescence. , 1985, Physics in medicine and biology.

[12]  L J Somervaille,et al.  Lead in bone: sampling and quantitation using K X-rays excited by 109Cd. , 1991, Environmental health perspectives.

[13]  P. R. Bevington,et al.  Data Reduction and Error Analysis for the Physical Sciences , 1969 .

[14]  F. Speizer,et al.  Correlates of bone and blood lead levels among middle-aged and elderly women. , 2002, American journal of epidemiology.

[15]  M. Thun,et al.  Prospective study of cigarette smoking and amyotrophic lateral sclerosis. , 2004, American journal of epidemiology.

[16]  B. Schwartz,et al.  Adult Lead Exposure: Time for Change , 2006, Environmental health perspectives.

[17]  Howard Hu,et al.  Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. , 1998, Environmental health perspectives.

[18]  A. Rotnitzky,et al.  The relationship of bone and blood lead to hypertension. The Normative Aging Study. , 1996, JAMA.

[19]  J Schwartz,et al.  Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. , 2001, American journal of epidemiology.

[20]  D. Chettle,et al.  Improvements in the precision of in vivo bone lead measurements. , 1989, Physics in medicine and biology.

[21]  B. Schwartz,et al.  Changes in Systolic Blood Pressure Associated With Lead in Blood and Bone , 2006, Epidemiology.

[22]  Howard Hu,et al.  X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead. , 1989, Environmental research.

[23]  A. Todd,et al.  In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies. , 1992, Environmental research.

[24]  A. Todd,et al.  Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. , 2002, American journal of epidemiology.

[25]  J. Schwartz.  Secondary Sulfate Effects? , 2007, Environmental health perspectives.

[26]  Howard Hu,et al.  Effect of Maternal Bone Lead on Length and Head Circumference of Newborns and 1-Month-Old Infants , 2002, Archives of environmental health.

[27]  A. Todd.  Calculating bone-lead measurement variance. , 1999, Environmental health perspectives.

[28]  F. McNeill,et al.  An investigation of the 109Cd gamma-ray induced K-x-ray fluorescence (XRF) bone-lead measurement calibration procedure. , 2004, Physics in medicine and biology.

[29]  J. Schwartz,et al.  A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. , 2002, Environmental health perspectives.

[30]  C. Gordon,et al.  The reproducibility of 109Cd-based X-ray fluorescence measurements of bone lead. , 1994, Environmental health perspectives.

[31]  K Lidén,et al.  X-ray fluorescence analysis of lead in human skeleton in vivo. , 1976, Scandinavian journal of work, environment & health.

[32]  C. Amarasiriwardena,et al.  Validation of K x-ray fluorescence bone lead measurements by inductively coupled plasma mass spectrometry in cadaver legs. , 2000, Medical physics.

[33]  J. Schwartz,et al.  Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. , 2002, Pediatrics.

[34]  F. McNeill,et al.  Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements. , 1999, Physics in medicine and biology.

[35]  A. Spiro,et al.  Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. , 2004, American journal of epidemiology.

[36]  David R. Chettle,et al.  A study of MDL improvement for the in vivo measurement of lead in bone , 2004 .

[37]  David R. Chettle,et al.  In vivo investigation of a new 109Cd γ-ray induced K-XRF bone lead measurement system , 2006 .

[38]  F. McNeill,et al.  Lead in bone: storage site, exposure source, and target organ. , 1993, Neurotoxicology.

[39]  P. Quittner.  Peak area determination for Ge(Li) detector data , 1969 .

[40]  F. Speizer,et al.  Lead and hypertension in a sample of middle-aged women. , 1999, American journal of public health.

[41]  A. Todd,et al.  Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. , 1994, Physics in medicine and biology.

[42]  A. Savitzky,et al.  Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .

[43]  B S Schwartz,et al.  Environmental lead exposure and cognitive function in community-dwelling older adults , 2006, Neurology.

[44]  A. Todd.  Contamination of in vivo bone-lead measurements. , 2000, Physics in medicine and biology.

[45]  C. Gordon,et al.  An improved instrument for the in vivo detection of lead in bone. , 1993, British journal of industrial medicine.

[46]  M. Dana,et al.  Accumulated lead exposure and risk of age-related cataract in men. , 2004, JAMA.

[47]  S Skerfving,et al.  In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites. , 1989, Physics in medicine and biology.

[48]  F. McNeill,et al.  Performance appraisals of digital spectroscopy systems for the measurement of bone lead. , 2000, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[49]  A. Todd,et al.  Corrections to "How to calculate lead concentration and concentration uncertainty in XRF in vivo bone lead analysis" by Kondrashov and Rothenberg. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[50]  I. H. Tipton,et al.  The human body burden of lead. , 1968, Archives of environmental health.